References

Eosinophilic granulomatosis with polyangiitis—advances in pathogenesis, diagnosis, and treatment

2023 · External reference

Eosinophilic granulomatosis with polyangiitis: a review

10.1016/j.autrev.2022.103219 · 2023 · External reference

Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis

10.1007/s10067-021-05783-8 · 2021 · External reference

Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United States

2021 · External reference

Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK

10.1183/23120541.00430-2023 · 2024 · External reference

Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate

10.1002/art.20077 · 2004 · External reference

Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg–Strauss syndrome within a defined population in southern Sweden

10.1093/rheumatology/kem107 · 2007 · External reference

Burden of eosinophilic granulomatosis with polyangiitis in Europe

10.1183/23120541.00912-2023 · 2024 · External reference

Systematic literature review and meta-analysis of the epidemiology and clinical burden of eosinophilic granulomatosis with polyangiitis

10.1093/mr/roaf014 · 2025 · External reference

Trends in prevalence, treatment use, and disease burden in patients with eosinophilic granulomatosis with polyangiitis in Japan: real-world database analysis

10.1093/mr/road104 · 2024 · External reference

Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

10.1183/13993003.00097-2016 · 2016 · External reference

Heart disease in eosinophilic granulomatosis with polyangiitis (EGPA) patients: a screening approach proposal

10.1093/rheumatology/keab027 · 2021 · External reference

10.1097/01.md.0000158825.87055.0b

10.1097/01.md.0000158825.87055.0b · 2005 · External reference

Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors

10.1016/j.autrev.2014.08.002 · 2014 · External reference

Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases

10.1093/rheumatology/keaa416 · 2021 · External reference

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

10.1002/art.37721 · 2013 · External reference

Clinical manifestations and long-term outcomes of eosinophilic granulomatosis with polyangiitis in North America

10.1002/acr2.11263 · 2021 · External reference

Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials

10.1016/j.jaut.2013.03.003 · 2013 · External reference

2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis

10.1002/art.41773 · 2021 · External reference

EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

10.1136/ard-2022-223764 · 2024 · External reference

Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

10.1038/s41584-023-00958-w · 2023 · External reference

The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis

10.1093/rheumatology/keaf240 · 2025 · External reference

Eosinophilic granulomatosis with polyangiitis: current status and future perspectives

10.1016/j.resinv.2025.04.018 · 2025 · External reference

Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitis

10.1136/rmdopen-2023-003956 · 2024 · External reference

Long-term followup of a multicenter cohort of 101 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

10.1002/acr.22686 · 2016 · External reference

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

10.1136/ard.2008.101279 · 2009 · External reference

Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides

10.1002/art.1780400222 · 1997 · External reference

Mortality in systemic necrotizing vasculitides: a retrospective analysis of the French Vasculitis Study Group registry

10.1016/j.autrev.2018.01.022 · 2018 · External reference

A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients

10.1136/annrheumdis-2012-201531 · 2013 · External reference

Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis

10.1016/j.rmed.2018.07.017 · 2018 · External reference

Characteristics of severe asthma clinic patients with eosinophilic granulomatosis with polyangiitis

10.1016/j.jaip.2024.10.013 · 2025 · External reference

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis

10.1093/rheumatology/ket445 · 2014 · External reference

Diagnosis and management of eosinophilic granulomatosis with polyangiitis: perspective from the severe asthma clinic

2022 · External reference

Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management

10.1093/rheumatology/kez570 · 2020 · External reference

Incidence, prevalence, and mortality of eosinophilic granulomatosis with polyangiitis in Korea: a nationwide population-based study

10.4168/aair.2024.16.2.168 · 2024 · External reference

Highlights from the plenary session: eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome

10.1093/rheumatology/keae608 · 2025 · External reference